The first series of MOTUS lumbar total joint replacement surgeries as part of the BalancedBack pivotal clinical trial sponsored by 3Spine has been successfully completed. The study aims to compare outcomes for patients treated with the new low back total joint reconstruction to patients who received a traditional spinal fusion in a separate prospective 3Spine study. Dr. Khachatryan completed the initial series of MOTUS surgeries at the Global Microsurgical Center of Park City and will enroll a limited number of additional patients from the greater Salt Lake City area over the coming months.

3Spine’s lumbar total joint replacement procedure and MOTUS device is a ‘first-of-kind’ technology replacing the function of the disc and facet joints through a posterior approach. The procedure is intended to broadly address leg pain, back pain, and spinal instability, while correcting posture and allowing freedom of movement. Much like a hip or knee replacement, the procedure treats degenerative disease through reconstruction of the spinal total joint.

3Spine, Inc. is seeking single-level indications from L1-S1 in patients suffering from lumbar degeneration with or without foraminal or recess spinal stenosis with no more than a grade 1 spondylolisthesis at the involved level. Additional details are available at ClinicalTrials.gov. Patients in the Greater Salt Lake City area interested in participating in the clinical trial can contact Aubrey Cicon at aubriannacicon@centura.org for more information.

About 3Spine:
3Spine, Inc. is a private, clinical phase healthcare company headquartered in Chattanooga, Tennessee, dedicated to advancing patient care through the development of lumbar (low back) total joint replacement as an alternative to spinal fusion. The company’s breakthrough MOTUS technology is designed to preserve natural balance and range of motion in all postures, allowing patients to live a more active, pain-free life. Learn more by visiting www.3spine.com.